Sources | Names Used |
---|---|
CTRPv2 | selumetinib:decitabine (4:1 mol/mol) |
PharmacoGx | selumetinib:decitabine (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ABO | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
mRNA | TBC1D19 | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-06 |
mRNA | CTDSPL | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-06 |
mRNA | TCEAL4 | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-06 |
mRNA | MSRB3 | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-06 |
mRNA | GPX8 | CTRPv2 | pan-cancer | AAC | -0.2 | 5e-06 |
mRNA | TMED7-TICAM2 | CTRPv2 | pan-cancer | AAC | -0.18 | 6e-06 |
mRNA | GLTSCR2 | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-06 |
mRNA | TRIB2 | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-06 |
mRNA | DSE | CTRPv2 | pan-cancer | AAC | -0.17 | 7e-06 |